141 related articles for article (PubMed ID: 16091499)
1. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
Cebrian A; Lesueur F; Martin S; Leyland J; Ahmed S; Luccarini C; Smith PL; Luben R; Whittaker J; Pharoah PD; Dunning AM; Ponder BA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6268-74. PubMed ID: 16091499
[TBL] [Abstract][Full Text] [Related]
2. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
Fernández RM; Peciña A; Antiñolo G; Navarro E; Borrego S
Thyroid; 2006 Apr; 16(4):411-7. PubMed ID: 16646689
[TBL] [Abstract][Full Text] [Related]
3. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.
Ruiz-Llorente S; Montero-Conde C; Milne RL; Moya CM; Cebrián A; Letón R; Cascón A; Mercadillo F; Landa I; Borrego S; Pérez de Nanclares G; Alvarez-Escolá C; Díaz-Pérez JA; Carracedo A; Urioste M; González-Neira A; Benítez J; Santisteban P; Dopazo J; Ponder BA; Robledo M;
Cancer Res; 2007 Oct; 67(19):9561-7. PubMed ID: 17909067
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.
Figlioli G; Landi S; Romei C; Elisei R; Gemignani F
Mutat Res; 2013; 752(1):36-44. PubMed ID: 23059849
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
Baumgartner-Parzer SM; Lang R; Wagner L; Heinze G; Niederle B; Kaserer K; Waldhäusl W; Vierhapper H
J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333
[TBL] [Abstract][Full Text] [Related]
6. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
Severskaia NV; Saenko VA; Il'in AA; Chebotareva IV; Rumiantsev PO; Isaev PA; Medvedev VS; Iasmita S
Mol Biol (Mosk); 2006; 40(3):425-35. PubMed ID: 16813162
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H
Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
[TBL] [Abstract][Full Text] [Related]
8. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.
Fugazzola L; Muzza M; Mian C; Cordella D; Barollo S; Alberti L; Cirello V; Dazzi D; Girelli ME; Opocher G; Beck-Peccoz P; Persani L
Clin Endocrinol (Oxf); 2008 Sep; 69(3):418-25. PubMed ID: 18284634
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.
Ceolin L; Siqueira DR; Ferreira CV; Romitti M; Maia SC; Leiria L; Crispim D; Ashton-Prolla P; Maia AL
Eur J Endocrinol; 2012 May; 166(5):847-54. PubMed ID: 22345297
[TBL] [Abstract][Full Text] [Related]
10. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.
Borrego S; Fernández RM; Dziema H; Japón MA; Marcos I; Eng C; Antiñolo G
Thyroid; 2002 Nov; 12(11):1017-22. PubMed ID: 12490080
[TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphisms: implications in the pathogenesis of medullary thyroid carcinoma].
Rocha AP; Magalhães PK; Maia AL; Maciel LM
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):723-30. PubMed ID: 17891235
[TBL] [Abstract][Full Text] [Related]
13. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
Cardot-Bauters C; Leteurtre E; Leclerc L; Vantyghem MC; Do Cao C; Wemeau JL; d'Herbomez M; Carnaille B; Barbu V; Pinson S; Pigny P;
Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
[TBL] [Abstract][Full Text] [Related]
14. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
15. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
McWhinney SR; Boru G; Binkley PK; Peczkowska M; Januszewicz AA; Neumann HP; Eng C
J Clin Endocrinol Metab; 2003 Oct; 88(10):4911-6. PubMed ID: 14557473
[TBL] [Abstract][Full Text] [Related]
16. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
18. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
[TBL] [Abstract][Full Text] [Related]
19. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
[TBL] [Abstract][Full Text] [Related]
20. RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.
Abdelhakim A; Barlier A; Kebbou M; Benabdeljalil N; Timinouni M; Taoufiq F; Roche C; El Antri S
J Cancer Res Ther; 2009; 5(3):198-202. PubMed ID: 19841562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]